Drugmakers aim big price hikes at U.S. patients, congressional report finds

The report, put out following a nearly three-year probe, took issue with assertions by the pharmaceutical industry that high drug prices were needed to fund innovation and research and development programs.

Related Keywords

Colorado ,United States ,Washington ,American ,A Novo Nordisk ,Amgen Enbrel ,Ahmed Aboulenein ,Carolyn Maloney ,Diane Bartz ,Eli Lilly ,Mallinckrodt Acthar ,Abbvie Humira ,Celgene Revlimid ,Industrie Copaxone ,Bristol Myers ,Amgen ,Pfizer ,Pfizer Inc ,Bristol Myers Squibb ,Novo Nordisk ,Novartis ,Chairwoman Carolyn Maloney ,Joe Biden ,Build Back Better ,Teva Pharmaceutical Industrie Copaxone ,Additional Reporting ,Bill Berkrot ,